Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
Publié dans: | Case Reports in Critical Care (2019)5362514, S. 6 |
---|---|
Auteurs principaux: | Kirchner, Carmen (Auteur), Sibai, Jasmin (Auteur), Schwier, Elke (Auteur), Henzler, Dietrich (Auteur), Eickmeyer, Claas (Auteur), Winde, Günther (Auteur), Köhler, Thomas (Auteur) |
Format: | Article |
Langue: | English |
Publié: |
2019
|
Sujets: | |
Accès en ligne: | https://doi.org/10.1155/2019/5362514 |
Documents similaires: | In:
Case Reports in Critical Care |
Documents similaires
-
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
par: Schwier, Elke, et autres
Publié: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
par: Unterberg, Matthias, et autres
Publié: (2022) -
Pericarditis caused by Enterococcus faecium with acute liver failure treated by a multifaceted approach including antimicrobials and hemoadsorption
par: Köhler, Thomas, et autres
Publié: (2021) -
Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock : a prospective study.
par: Praxenthaler, Janina, et autres
Publié: (2022) -
Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine : A prospective, national, multicenter, non-interventional study-the HYPOTENS trial.
par: Eberhart, L., et autres
Publié: (2021)